Thomas Gad, CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 32,351 shares at $13.00 ($396K) on 2024-05-23, disclosed to the SEC on 2024-05-23.
Seasonal sale ($396k) by CHIEF BUSINESS OFFICER — this insider has traded YMAB in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 25,000 | $300K | 75.8% |
| 2 | $13.00 | 7,351 | $96K | 24.2% |
| Total | $12.23 avg | 32,351 | $396K | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |
| YMAB | SELL | 2023-12-15 | $1.0M | — | Filing → |